216 related articles for article (PubMed ID: 15942349)
1. Carvedilol reverses hyperthermia and attenuates rhabdomyolysis induced by 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy) in an animal model.
Sprague JE; Moze P; Caden D; Rusyniak DE; Holmes C; Goldstein DS; Mills EM
Crit Care Med; 2005 Jun; 33(6):1311-6. PubMed ID: 15942349
[TBL] [Abstract][Full Text] [Related]
2. Toward directed therapy for amphetamine-mediated hyperthermia: is carvedilol worth raving about?
Jackson WL
Crit Care Med; 2005 Jun; 33(6):1443-5. PubMed ID: 15942381
[No Abstract] [Full Text] [Related]
3. Attenuation of 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy)-induced rhabdomyolysis with alpha1- plus beta3-adrenoreceptor antagonists.
Sprague JE; Brutcher RE; Mills EM; Caden D; Rusyniak DE
Br J Pharmacol; 2004 Jun; 142(4):667-70. PubMed ID: 15159279
[TBL] [Abstract][Full Text] [Related]
4. Carvedilol inhibits the cardiostimulant and thermogenic effects of MDMA in humans.
Hysek C; Schmid Y; Rickli A; Simmler LD; Donzelli M; Grouzmann E; Liechti ME
Br J Pharmacol; 2012 Aug; 166(8):2277-88. PubMed ID: 22404145
[TBL] [Abstract][Full Text] [Related]
5. Risperidone attenuates and reverses hyperthermia induced by 3,4-methylenedioxymethamphetamine (MDMA) in rats.
Shioda K; Nisijima K; Yoshino T; Kuboshima K; Iwamura T; Yui K; Kato S
Neurotoxicology; 2008 Nov; 29(6):1030-6. PubMed ID: 18722468
[TBL] [Abstract][Full Text] [Related]
6. Hypothalamic-pituitary-thyroid axis and sympathetic nervous system involvement in hyperthermia induced by 3,4-methylenedioxymethamphetamine (Ecstasy).
Sprague JE; Banks ML; Cook VJ; Mills EM
J Pharmacol Exp Ther; 2003 Apr; 305(1):159-66. PubMed ID: 12649364
[TBL] [Abstract][Full Text] [Related]
7. MDMA, Methylone, and MDPV: Drug-Induced Brain Hyperthermia and Its Modulation by Activity State and Environment.
Kiyatkin EA; Ren SE
Curr Top Behav Neurosci; 2017; 32():183-207. PubMed ID: 27677782
[TBL] [Abstract][Full Text] [Related]
8. Clozapine reverses hyperthermia and sympathetically mediated cutaneous vasoconstriction induced by 3,4-methylenedioxymethamphetamine (ecstasy) in rabbits and rats.
Blessing WW; Seaman B; Pedersen NP; Ootsuka Y
J Neurosci; 2003 Jul; 23(15):6385-91. PubMed ID: 12867524
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms mediating the ability of caffeine to influence MDMA ('Ecstasy')-induced hyperthermia in rats.
Vanattou-Saïfoudine N; McNamara R; Harkin A
Br J Pharmacol; 2010 Jun; 160(4):860-77. PubMed ID: 20590585
[TBL] [Abstract][Full Text] [Related]
10. Clinically Relevant Pharmacological Strategies That Reverse MDMA-Induced Brain Hyperthermia Potentiated by Social Interaction.
Kiyatkin EA; Ren S; Wakabayashi KT; Baumann MH; Shaham Y
Neuropsychopharmacology; 2016 Jan; 41(2):549-59. PubMed ID: 26105141
[TBL] [Abstract][Full Text] [Related]
11. The role of mitochondrial uncoupling in 3,4-methylenedioxymethamphetamine-mediated skeletal muscle hyperthermia and rhabdomyolysis.
Rusyniak DE; Tandy SL; Hekmatyar SK; Mills E; Smith DJ; Bansal N; MacLellan D; Harper ME; Sprague JE
J Pharmacol Exp Ther; 2005 May; 313(2):629-39. PubMed ID: 15644431
[TBL] [Abstract][Full Text] [Related]
12. The effects of mirtazapine and fluoxetine on hyperthermia induced by 3,4-methylenedioxymethamphetamine (MDMA) in rats.
Kasai M; Shioda K; Nisijima K; Yoshino T; Iwamura T; Kato S
Neurosci Lett; 2011 Jul; 499(1):24-7. PubMed ID: 21621587
[TBL] [Abstract][Full Text] [Related]
13. Minocycline attenuates 3,4-methylenedioxymethamphetamine-induced hyperthermia in the rat brain.
Musolino ST; Schartner EP; Hutchinson MR; Salem A
Eur J Pharmacol; 2019 Sep; 858():172495. PubMed ID: 31238065
[TBL] [Abstract][Full Text] [Related]
14. Effects of MDMA alone and after pretreatment with reboxetine, duloxetine, clonidine, carvedilol, and doxazosin on pupillary light reflex.
Hysek CM; Liechti ME
Psychopharmacology (Berl); 2012 Dec; 224(3):363-76. PubMed ID: 22700038
[TBL] [Abstract][Full Text] [Related]
15. MDMA induced hyperthermia: report of a fatality and review of current therapy.
Dar KJ; McBrien ME
Intensive Care Med; 1996 Sep; 22(9):995-6. PubMed ID: 8905441
[TBL] [Abstract][Full Text] [Related]
16. Role of the serotonin 5-HT2A receptor in the hyperlocomotive and hyperthermic effects of (+)-3,4-methylenedioxymethamphetamine.
Herin DV; Liu S; Ullrich T; Rice KC; Cunningham KA
Psychopharmacology (Berl); 2005 Apr; 178(4):505-13. PubMed ID: 15765263
[TBL] [Abstract][Full Text] [Related]
17. Memantine attenuates 3,4-methylenedioxymethamphetamine-induced hyperthermia in rats.
Nisijima K; Kuboshima K; Shioda K; Yoshino T; Iwamura T; Kato S
Neurosci Lett; 2012 Dec; 531(2):198-203. PubMed ID: 23142720
[TBL] [Abstract][Full Text] [Related]
18. The role of monoamines in the changes in body temperature induced by 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) and its derivatives.
Docherty JR; Green AR
Br J Pharmacol; 2010 Jul; 160(5):1029-44. PubMed ID: 20590597
[TBL] [Abstract][Full Text] [Related]
19. Fatal multi-organ failure after suicidal overdose with MDMA, 'ecstasy': case report and review of the literature.
Walubo A; Seger D
Hum Exp Toxicol; 1999 Feb; 18(2):119-25. PubMed ID: 10100025
[TBL] [Abstract][Full Text] [Related]
20. Caffeine promotes hyperthermia and serotonergic loss following co-administration of the substituted amphetamines, MDMA ("Ecstasy") and MDA ("Love").
McNamara R; Kerans A; O'Neill B; Harkin A
Neuropharmacology; 2006 Jan; 50(1):69-80. PubMed ID: 16188283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
